John D. Mendlein, Ph.D., J.D.
DirectoratFate Therapeutics· In proxies 2023–2025
John D. Mendlein, Ph.D., J.D. is Director of Fate Therapeutics.
Experience
- Fate TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -79%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?